KaloCyte, Inc. Employee Directory
Biotechnology ResearchMaryland, United States11-50 Employees
KaloCyte, Inc. is a preclinical biotechnology company based in Baltimore, Maryland, operating as an affiliate of the University of Maryland, Baltimore and the UM BioPark within the Center for Blood Oxygen Transport and Hemostasis. Founded in 2016 by researchers from Washington University in St. Louis, it is developing ErythroMer, a dried, bio-inspired artificial red blood cell designed for use when stored donor blood is unavailable or in short supply. The product is intended to carry oxygen without requiring blood typing or cross-matching, supporting clinical care in settings where conventional transfusions are limited. Its target customers are clinicians and health systems facing blood supply challenges and seeking alternatives to stored red blood cells in emergencies or austere environments. In 2025, KaloCyte announced an exclusive license and collaboration with Chrysea Labs to integrate biosynthetic hemoglobin production with ErythroMer, forming a global partnership to advance the technology.